Am J Perinatol 2022; 29(14): 1548-1554
DOI: 10.1055/s-0041-1722944
Original Article

Cord-Blood High-Sensitivity Troponin-I Reference Interval and Association with Early Neonatal Outcomes

Tapas Mondal*
1   Department of Pediatrics, McMaster Children's Hospital, Hamilton, Ontario, Canada
,
Paul M. Ryan*
2   Brookfield School of Medicine and Health Sciences, University College Cork, Cork, Ireland
,
Kaaran Gupta
1   Department of Pediatrics, McMaster Children's Hospital, Hamilton, Ontario, Canada
,
George Radovanovic
1   Department of Pediatrics, McMaster Children's Hospital, Hamilton, Ontario, Canada
,
Edward Pugh
1   Department of Pediatrics, McMaster Children's Hospital, Hamilton, Ontario, Canada
,
Anthony K. C. Chan
1   Department of Pediatrics, McMaster Children's Hospital, Hamilton, Ontario, Canada
,
Stephen Hill
3   Department of Pathology and Molecular Medicine, McMaster University, Hamilton, Ontario, Canada
4   Laboratory Medicine, Hamilton Regional Laboratory Medicine Program, Hamilton, Ontario, Canada
› Author Affiliations

Funding No extramural funding was sought for this study. Reagents were provided as a grant-in-aid by Abbott Diagnostics, Canada. However, Abbott Diagnostics played no role in study design or implementation, data analysis, or preparation of the manuscript.
Preview

Abstract

Objective This study was aimed to establish a reference interval for high-sensitivity cardiac troponin I (hs-cTnI) in umbilical cord blood of infants and to assess its association with the risk of predetermined early neonatal outcomes in a high-acuity tertiary care hospital.

Study Design Umbilical cord-blood samples were collected and hs-cTnI was measured in all infants born between August 2015 and September 2015 at McMaster Children's Hospital (n = 256). Gestational age, birth weight, Apgar's scores, age in days at which feeding was established, neonatal intensive care unit (NICU) admission, and discharge in days after birth were recorded.

Results The 90th, 95th, and 99th percentiles for the term infant subcohort were 19.75, 41.45, and 166.30 ng/L, respectively. We observed decreased mean gestational ages and birth weights in both the 90th (37.7 weeks; 2,961.4 g) and 95th percentiles (37.1 weeks; 2,709.9 g) when compared with the remaining infants. Moreover, levels of hs-cTnI were significantly higher in infants with respiratory distress requiring intervention (p < 0.05), low birth weight infants (p < 0.01), preterm infants (p < 0.001), and those requiring NICU admission (p < 0.01). Multiple linear regression of the recorded demographic factors revealed prematurity (gestational age <35 weeks: coefficient 0.346 ± 0.160, p < 0.05; gestational age <37 weeks: coefficient 0.253 ± 0.105, p < 0.05) and male sex (coefficient 0.138 ± 0.047; p < 0.01) to be most predictive of log-hs-cTnI levels.

Conclusion This study establishes the reference values for cord-blood hs-cTnI in infants at a tertiary care center. Premature and sick infants requiring NICU admission had significantly higher levels of hs-cTnI.

Key Points

  • Established the 90th, 95th, and 99th percentiles of neonatal cord-blood hs-cTnI in term infants as 19.75, 41.45, and 166.30 ng/L, respectively.

  • Infants with hs-cTnI levels exceeding the 90th percentile had lower gestational ages and birth weights with higher rates of NICU admissions.

  • Infants with respiratory distress or requiring NICU admission were found to have higher levels of hs-cTnI.

* Co–first authorship: These authors contributed equally to this manuscript.




Publication History

Received: 19 April 2020

Accepted: 18 December 2020

Article published online:
06 February 2021

© 2021. Thieme. All rights reserved.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA